Search results
Results From The WOW.Com Content Network
Polycystic ovary syndrome (PCOS) is the most common hormonal condition in women during their reproductive years. Yet no one knows precisely what causes it, and it has no cure. PCOS is a common ...
Polycystic ovary syndrome, or polycystic ovarian syndrome (PCOS), is the most common endocrine disorder in women of reproductive age. [14] The syndrome is named after cysts which form on the ovaries of some women with this condition, though this is not a universal symptom and not the underlying cause of the disorder.
Theca lutein cyst is a type of bilateral functional ovarian cyst filled with clear, straw-colored fluid. These cysts result from exaggerated physiological stimulation (hyperreactio luteinalis) due to elevated levels of beta-human chorionic gonadotropin (beta-hCG) or hypersensitivity to beta-hCG.
Most ovarian cysts are related to ovulation, being either follicular cysts or corpus luteum cysts. [1] Other types include cysts due to endometriosis, dermoid cysts, and cystadenomas. [1] Many small cysts occur in both ovaries in polycystic ovary syndrome (PCOS). [1] Pelvic inflammatory disease may also result in cysts. [1]
Ultrasound of a polycystic ovary. Each of the dark circles represents a fluid-filled cyst. Polycystic ovary syndrome (PCOS) is an endocrine disorder characterized by an excess of androgens produced by the ovaries. It is estimated that approximately 90% of women with PCOS demonstrate hypersecretion of these hormones. [18]
During ultrasound examinations, sometimes echogenicity is higher in certain parts of body. Fatty liver could cause increased echogenicity in the liver, especially if the liver transaminases are elevated. [3] Women with polycystic ovary syndrome may also show an increase in stromal echogenicity.
It plays a central role in the multiple imbalances and dysfunctions of polycystic ovary syndrome. During the first two years after menarche 50% of the menstrual cycles could be anovulatory cycles. It is in fact possible to restore ovulation using appropriate medication, and ovulation is successfully restored in approximately 90% of cases.
Injection of hCG as a trigger for ovulation confers a risk of ovarian hyperstimulation syndrome, especially in patients with polycystic ovary syndrome who have been hyperstimulated during previous assisted reproduction cycles. [12] Complications of TVOR include injury to pelvic organs, hemorrhage, and infection.